Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-02-26 @ 2:16 AM
Study NCT ID:
NCT00044135
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2002-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Sponsor:
Triangle Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-08-20
First Submit QC Date:
None
Study First Post Date:
2002-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-06-23
Last Update Post Date:
2005-06-24
Last Update Post Date Type:
ESTIMATED